• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medical device companies fear parallel regulation after Brexit vote

Medical device companies fear parallel regulation after Brexit vote

June 30, 2016 By Fink Densford

European Union flagMedical Device companies fear that Britain’s exit from the European Union could result in a “parallel” regulatory system which would require them to file separate applications to access the U.K. and E.U markets, according to a new report from ScienceBusiness.

Only 2 weeks ago, the Environment, Public Health and Food Safety Committee of the European Parliament and Council’s Committee of Permanent Representatives voted to endorse new medical device and in vitro diagnostic regulations.

The approval paves the way for for the adoption of 2 new draft regulations by the end of 2016, though the new rules would not take effect for 3 years in relation to medical devices and 5 years for IVD. The regulations cover the design, manufacturing and clinical testing of medical devices and in vitro diagnostics, and will affect all device manufacturing and sales in the E.U.

Whether those regulations will now apply to products in the U.K. is still uncertain, according to the report from ScienceBusiness.

“From a business perspective it is hard to see an upside to the UK’s decision to leave the EU. Britain’s influence in the development of the European MedTech regulatory environment has been extremely positive and we now face an uncertain situation with possible regulatory divergence over time,” Cook Medical EMEA exec veep Bill Doherty told ScienceBusiness.

Currently, medical devices can be marketed throughout the E.U. with only CE Mark approval by any of the approximately 70 notified bodies which are overseen by national regulators.

“It’s a question of what they will be able to rescue from the wreckage. If a deal cannot be done, device manufacturers would need to go through approval twice, once for the U.K. market and once for the EU market, and I don’t see any value in that for anyone,” U.K. Health Research Authority research ethics advisor Hugh Davies told ScienceBusiness.

Davies said he expects the country will try to keep things “as harmonised as possible,” which would allow for the mutual recognition of U.K. and EU notified bodies, with the U.K. following the previously agreed upon rules and regulations.

“The U.K. MHRA has been incredibly influential in leading on so many aspects of how healthcare products are regulated. Now we are marginalized. We may be invited to the table but won’t have a voice,” Davies told ScienceBusiness.

Filed Under: Regulatory/Compliance Tagged With: European Union

More recent news

  • A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology
  • Dexcom continues advances in AI for CGM, type 2 diabetes awareness
  • Tandem continues to deliver more options, benefits for those with diabetes
  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy